Teng Yang

429 total citations
12 papers, 356 citations indexed

About

Teng Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Teng Yang has authored 12 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Teng Yang's work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). Teng Yang is often cited by papers focused on MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). Teng Yang collaborates with scholars based in China and United States. Teng Yang's co-authors include Gang Liu, Haili Huang, Lawei Yang, Yahong Wang, Huijuan He, Yun Jiang, Ziying Lin, Ting Chen, Weimin Yao and David W. Kamp and has published in prestigious journals such as Cancer Letters, Oncotarget and Cellular Signalling.

In The Last Decade

Teng Yang

12 papers receiving 352 citations

Peers

Teng Yang
Meng Jiao China
Cynthia C. Jose United States
Lishi Xie United States
Teng Yang
Citations per year, relative to Teng Yang Teng Yang (= 1×) peers Fulvio D’Angelo

Countries citing papers authored by Teng Yang

Since Specialization
Citations

This map shows the geographic impact of Teng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng Yang more than expected).

Fields of papers citing papers by Teng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng Yang. The network helps show where Teng Yang may publish in the future.

Co-authorship network of co-authors of Teng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Teng Yang. A scholar is included among the top collaborators of Teng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng Yang. Teng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Liu, Lu, Xiangxiang Jin, Zhe Shen, et al.. (2021). C1632 suppresses the migration and proliferation of non‐small‐cell lung cancer cells involving LIN28 and FGFR1 pathway. Journal of Cellular and Molecular Medicine. 26(2). 422–435. 11 indexed citations
2.
He, Jintao, Teng Yang, Wenhui He, et al.. (2020). Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5p/FOXM1 axis. Cellular Signalling. 74. 109720–109720. 18 indexed citations
3.
Yang, Teng, Peng Zheng, Haiyan Xiao, et al.. (2018). SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis. Cellular Physiology and Biochemistry. 48(1). 397–397. 34 indexed citations
4.
Pang, Lei, et al.. (2018). lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin�D1. Oncology Reports. 40(5). 2507–2514. 26 indexed citations
5.
Huang, Haili, Huijuan He, Yahong Wang, et al.. (2017). MiR-4673 Modulates Paclitaxel-Induced Oxidative Stress and Loss of Mitochondrial Membrane Potential by Targeting 8-Oxoguanine-DNA Glycosylase-1. Cellular Physiology and Biochemistry. 42(3). 889–900. 28 indexed citations
6.
Li, Bo, Xinzhe Li, Haojun Xiong, et al.. (2017). Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells. Oncotarget. 8(31). 51748–51757. 15 indexed citations
7.
Yang, Lawei, Yahong Wang, Ziying Lin, et al.. (2015). Mitochondrial OGG1 protects against PM2.5-induced oxidative DNA damage in BEAS-2B cells. Experimental and Molecular Pathology. 99(2). 365–373. 41 indexed citations
8.
Zhang, Xu, Teng Yang, Fang� Yang, et al.. (2015). MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas. Oncology Reports. 33(5). 2599–2605. 45 indexed citations
9.
Huang, Haili, Yun Jiang, Yahong Wang, et al.. (2015). miR-5100 promotes tumor growth in lung cancer by targeting Rab6. Cancer Letters. 362(1). 15–24. 58 indexed citations
10.
Huang, Haili, Yun Jiang, Yahong Wang, et al.. (2015). FBXO31 promotes cell proliferation, metastasis and invasion in lung cancer.. PubMed. 5(5). 1814–22. 28 indexed citations
11.
Wang, Yahong, Ziying Lin, Haili Huang, et al.. (2015). AMPK is required for PM2.5-induced autophagy in human lung epithelial A549 cells.. PubMed. 8(1). 58–72. 45 indexed citations
12.
Gu, Xiaoxia, Lu Yan, Ji Chen, et al.. (2012). Mechanisms mediating propofol protection of pulmonary epithelial cells against lipopolysaccharide‐induced cell death. Clinical and Experimental Pharmacology and Physiology. 39(5). 447–453. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026